CSIMarket
 


Aurinia Pharmaceuticals Inc   (AUPH)
Other Ticker:  
 
 

AUPH's Operating Income Growth by Quarter and Year

Aurinia Pharmaceuticals Inc 's Operating Income results by quarter and year




AUPH Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -29.67 -28.10 -32.71 -104.29
III Quarter September -16.26 -9.50 -50.35 -85.24
II Quarter June -16.17 -35.99 -47.13 0.00
I Quarter March -29.58 -37.88 -50.54 0.00
FY   -91.68 -111.47 -180.73 -189.53



AUPH Operating Income fourth quarter 2023 Y/Y Growth Comment
Aurinia Pharmaceuticals Inc in the fourth quarter 2023 recorded Operating Loss of $ -29.67 millions.

According to the results reported in the fourth quarter 2023, Aurinia Pharmaceuticals Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Aurinia Pharmaceuticals Inc ' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2023.

Explain Operating Income growth


AUPH Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Aurinia Pharmaceuticals Inc 's fourth quarter 2023 Operating Income $ -29.67 millions AUPH's Income Statement
Aurinia Pharmaceuticals Inc 's fourth quarter 2022 Operating Income $ -28.10 millions Quarterly AUPH's Income Statement
New: More AUPH's historic Operating Income Growth >>


AUPH Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Aurinia Pharmaceuticals Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AUPH's IV. Quarter Q/Q Operating Income Comment
Current accomplishment of -29.67 millions by Aurinia Pharmaceuticals Inc look even more unfavourable if you take a look at -16.26 millions Operating Loss a quarter before.

Within Major Pharmaceutical Preparations industry Aurinia Pharmaceuticals Inc achieved highest sequential Operating Income growth. While Aurinia Pharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AUPH's IV. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -29.67 millions by Aurinia Pharmaceuticals Inc appear even less good considering the -16.26 millions Operating Loss in the previous quarter.

Within Major Pharmaceutical Preparations industry Aurinia Pharmaceuticals Inc achieved highest sequential Operating Income growth. While Aurinia Pharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is .


Aurinia Pharmaceuticals Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ -91.69 $ -90.12 $ -83.35 $ -103.17 $ -111.47
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Aurinia Pharmaceuticals Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Aurinia Pharmaceuticals Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
AUPH's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for AUPH's Competitors
Operating Income Growth for Aurinia Pharmaceuticals Inc 's Suppliers
Operating Income Growth for AUPH's Customers

You may also want to know
AUPH's Annual Growth Rates AUPH's Profitability Ratios AUPH's Asset Turnover Ratio AUPH's Dividend Growth
AUPH's Roe AUPH's Valuation Ratios AUPH's Financial Strength Ratios AUPH's Dividend Payout Ratio
AUPH's Roa AUPH's Inventory Turnover Ratio AUPH's Growth Rates AUPH's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Idexx Laboratories Inc8.29%$ 8.288 millions
Surgery Partners Inc 7.64%$ 7.643 millions
Haemonetics Corporation6.24%$ 6.236 millions
Novartis Ag6.22%$ 6.219 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com